Sentinel node navigation for gastrointestinal cancers

Research output: Contribution to journalArticle

Abstract

Sentinel node biopsy has been clinically validated and applied for the surgical treatment for malignant melanoma and breast cancer. Although the feasibility of this technique in the other solid tumors including gastrointestinal (GI) cancer is still controversial, there are several reports to demonstrate diagnostic significance of SN mapping for early stage GI cancer. We have established radio-guided SN mapping for GI cancer and diagnostic accuracy according to this procedure in cT1N0 cases reached to 96%. The radioguided method allows us to detect the SN in endoscopic surgery quantitatively and reproducibly. Validation of the SN concept in GI cancer in a multi-centric clinical trial is essential for clinical application of this procedure, including the establishment of a novel, minimally invasive approach for early-stage GI cancer.

Original languageEnglish
Pages (from-to)1400-1403
Number of pages4
JournalJapanese Journal of Clinical Radiology
Volume46
Issue number11
Publication statusPublished - 2001 Jan 1

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Sentinel node navigation for gastrointestinal cancers'. Together they form a unique fingerprint.

  • Cite this